Alejandro González Veliz: Most Reported Aspirin Allergies Are Not True Hypersensitivity
Alejandro González Veliz, Interventional Cardiologist at Institute of Cardiology and Cardiovascular Surgery, shared a post on LinkedIn about recent article by Silvia Grimaldi et al., published in European Heart Journal, adding:
“Aspirin remains one of the most important drugs in cardiovascular medicine.
Yet many patients arrive with a history of ‘aspirin allergy,’ often leading clinicians to avoid a therapy that may be crucial after PCI, ACS, or valve interventions.
The reality?
Most reported reactions are not true hypersensitivity.
A careful history can distinguish intolerance from genuine allergy, and for selected patients, aspirin desensitization can safely restore access to guideline-directed therapy.
Understanding this distinction may prevent treatment delays, suboptimal antiplatelet strategies, and potentially avoidable cardiovascular events.”
Title: Aspirin hypersensitivity: a practical guide for cardiologists
Authors: Silvia Grimaldi, Paola Migliorini, Ilaria Puxeddu, Roberta Rossini, Raffaele De Caterina
Other posts featuring Alejandro González Veliz on Hemostasis Today.
-
Jun 9, 2026, 17:53Ajay Samkaria: How ABO Subgroups Directly Impact Transfusion Safety
-
Jun 9, 2026, 17:50Mary Cushman: It’s Time to Apply to Be on an ISTH SSC
-
Jun 9, 2026, 15:56Wolfgang Miesbach: A New Genetic Perspective on the Worldwide Burden of von Willebrand Disease
-
Jun 9, 2026, 15:34Shanon Marie Corsino: Nationwide Insights into Cancer-Associated Thrombosis in Filipino Patients
-
Jun 9, 2026, 15:20Murtuza Ali: Types of Blood Transfusions – A Quick Clinical Guide
-
Jun 9, 2026, 15:18Mital Jhaveri: TRACK Trial Findings Highlight the Unique Challenges of Advanced CKD
-
Jun 9, 2026, 14:56Mohamed Adel: Nursing Management of Patients with Thrombocytopenia
-
Jun 9, 2026, 14:31Mike Doss: The Critical Role of EMS in Preventing the Trauma Triad of Death
-
Jun 9, 2026, 14:13Kayla Garrett: Reducing False Positives and Improving Accuracy in APS